Robert W. Baird reiterated their hold rating on shares of LHC Group (NASDAQ:LHCG) in a report released on Tuesday. Robert W. Baird currently has a $63.00 price objective on the health services provider’s stock.

Several other research firms have also recently commented on LHCG. Zacks Investment Research cut LHC Group from a buy rating to a hold rating in a research report on Thursday, July 6th. Royal Bank Of Canada restated a buy rating and set a $70.00 target price on shares of LHC Group in a research report on Wednesday, September 6th. Jefferies Group LLC restated a buy rating and set a $65.00 target price on shares of LHC Group in a research report on Friday, June 9th. BidaskClub cut LHC Group from a strong-buy rating to a buy rating in a research report on Wednesday, July 12th. Finally, Bank of America Corporation began coverage on LHC Group in a research report on Monday, August 21st. They set a buy rating and a $76.00 target price for the company. One equities research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $66.60.

LHC Group (NASDAQ:LHCG) traded up 1.17% during mid-day trading on Tuesday, reaching $65.57. The company had a trading volume of 419,301 shares. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The stock has a market capitalization of $1.20 billion, a P/E ratio of 29.01 and a beta of 0.76. The stock has a 50 day moving average price of $63.46 and a 200-day moving average price of $59.66.

LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The business had revenue of $260.20 million during the quarter, compared to analysts’ expectations of $254.10 million. During the same period in the previous year, the business earned $0.52 earnings per share. The firm’s revenue was up 15.1% on a year-over-year basis. Equities analysts anticipate that LHC Group will post $2.39 EPS for the current fiscal year.

WARNING: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/16/lhc-group-lhcg-rating-reiterated-by-robert-w-baird.html.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is currently owned by corporate insiders.

Hedge funds have recently modified their holdings of the stock. Federated Investors Inc. PA boosted its holdings in LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after acquiring an additional 66 shares during the period. Acrospire Investment Management LLC boosted its holdings in LHC Group by 30.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after acquiring an additional 400 shares during the period. Cubist Systematic Strategies LLC boosted its holdings in LHC Group by 758.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after acquiring an additional 1,516 shares during the period. Invictus RG purchased a new stake in LHC Group during the 1st quarter valued at about $125,000. Finally, US Bancorp DE boosted its holdings in LHC Group by 25.1% during the 1st quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after acquiring an additional 539 shares during the period. Institutional investors own 85.93% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.